ORIC Pharmaceuticals gets grant for PLK4 inhibitors for treating cancer

2d ago, source: Pharmaceutical Technology

Discover how ORIC Pharmaceuticals Inc's patent for PLK4 inhibitors could revolutionize cancer treatment. Learn about the compound's potential and pharmaceutical applications.

ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC

3d ago, source:

Initiated multiple Phase 1b expansion cohorts to determine the RP2D of ORIC-114 in NSCLC patients with EGFR exon 20, HER2 exon 20, or EGFR ...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

13d ago, source:

The inducement grants were approved by ORIC’s Compensation Committee of the Board of Directors, as required by Nasdaq Rule 5635 (c) (4), and were granted as a material inducement to employment in ...

Bay Area exec loses groundbreaking 'shadow trading' trial

on MSN ago, source:

A San Francisco jury ruled against biotech executive Matthew Panuwat in his first-of-its-kind insider trading case, focused ...

Enliven Therapeutics adds physician to board

4d ago, source: BizWest

Enliven Therapeutics Inc., a clinical-stage precision oncology company, has appointed physician Lori Kunkel to its board of ...

Oric Pharmaceuticals reports on highly potent, selective and orally bioavailable PLK4 inhibitor

9d ago, source: BioWorld

The discovery of a potent, selective and orally bioavailable serine/threonine-protein kinase PLK4 (STK18) inhibitor with ...

Biotech ripe for ‘cascade of dealmaking’ - Here are the top companies to watch

on MSN ago, source:

Few corners of the market have been as prone to dealmaking over the last couple of years as the life sciences industry.

Community Health Systems gets grant for portable sleep diagnostic system for remote sleep apnea testing

2d ago, source: Pharmaceutical Technology

Revolutionize sleep diagnostics with Community Health Systems Inc's patented system, enabling remote testing for sleep apnea in multiple subjects. Real-time data collection and analysis for ...

World Metastatic Prostate Cancer Drug Landscape Research Report 2024: Comprehensive Insights about 90+ Companies and 110+ Pipeline Drugs

1d ago, source:

The "Metastatic Prostate Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 90+ companies and 110+ ...

TuHURA Biosciences, Inc. Appoints Dennis Yamashita, Ph.D., as Chief Scientific Officer and Head of Discovery Research and Early Development

7d ago, source:

Dr. Yamashita to focus on advancing the Company's novel personalized cancer vaccines to overcome tumor resistance to immunotherapies like checkpoint inhibitors and first-in-class bi-functional ...

Southern ITS International, Inc. Discusses Status on OTC Markets Group, Inc.

16d ago, source: Kansas City Star

SCOTTSDALE, AZ / ACCESSWIRE / April 2, 2024 / Southern ITS International, Inc. (OTC PINK:SITS) disclosed today that it ...

Phase II miss in PD cognitive impairment clips Sage

1d ago, source: BioWorld

Sage Therapeutics Inc. shares (NASDAQ:SAGE) were trading at $12.52, down $3.11, or almost 20%, after the Cambridge, Mass.-based firm rolled out top-line data from Precedent, a double-blind, ...